Showing results (191-200 of 435) with videos related to

Sort By:
Pageof 44
EJNMMI Radiopharmacy and Chemistry|August 14, 2023
In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancerAshleigh Hull, William Hsieh, William Tieu, et al.
EJNMMI Radiopharmacy and Chemistry|January 6, 2024
Cu(II)-Mediated direct 18F-dehydrofluorination of phosphine oxides in high molar activityXiaoqun Tang, Shengji Lv, Zhaobiao Mou, et al.
EJNMMI Radiopharmacy and Chemistry|January 2, 2024
Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2Robert Wodtke, Markus Laube, Sandra Hauser, et al.
EJNMMI Radiopharmacy and Chemistry|December 20, 2023
Chromatographic separation of silver-111 from neutron-irradiated palladium target: toward direct labeling of radiotracersMarianna Tosato, Andrea Gandini, Steffen Happel, et al.
EJNMMI Radiopharmacy and Chemistry|February 15, 2024
Intranasal administration enhances size-dependent pulmonary phagocytic uptake of poly(lactic-co-glycolic acid) nanoparticlesSeung Ho Baek, Eun-Ha Hwang, Gyeung Haeng Hur, et al.
EJNMMI Radiopharmacy and Chemistry|February 17, 2024
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncologyPanagiotis Kanellopoulos, Adam Mattsson, Ayman Abouzayed, et al.
EJNMMI Radiopharmacy and Chemistry|May 22, 2024
eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumorsDylan Chapeau, Savanne Beekman, Maryana Handula, et al.
EJNMMI Radiopharmacy and Chemistry|May 16, 2024
Highlight selection of radiochemistry and radiopharmacy developments by editorial boardJun Toyohara, Danielle Vugts, Oliver C Kiss, et al.
EJNMMI Radiopharmacy and Chemistry|November 20, 2023
Metallacages with 2,6-dipicolinoylbis(N,N-dialkylthioureas) as novel platforms in nuclear medicine for 68Ga, 177Lu and 198AuAnna Baitullina, Guilhem Claude, Suelen F Sucena, et al.
EJNMMI Radiopharmacy and Chemistry|October 11, 2023
Au@109Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of 109Pd/109mAg in vivo generator in combined β- auger electron therapyNasrin Abbasi Gharibkandi, Kamil Wawrowicz, Agnieszka Majkowska-Pilip, et al.
Pageof 44